58 related articles for article (PubMed ID: 8692395)
1. Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.
Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Neuwelt EA
Neurosurgery; 1996 Apr; 38(4):746-52; discussion 752-4. PubMed ID: 8692395
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of Gd-albumin delivery to the rat hippocampus in vivo by convection-enhanced delivery.
Kim JH; Astary GW; Nobrega TL; Kantorovich S; Carney PR; Mareci TH; Sarntinoranont M
J Neurosci Methods; 2012 Jul; 209(1):62-73. PubMed ID: 22687936
[TBL] [Abstract][Full Text] [Related]
3. Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery.
Iyer RR; Butman JA; Walbridge S; Gai ND; Heiss JD; Lonser RR
J Neurosurg; 2011 Sep; 115(3):474-80. PubMed ID: 21663409
[TBL] [Abstract][Full Text] [Related]
4. Influence of neuropathology on convection-enhanced delivery in the rat hippocampus.
Kantorovich S; Astary GW; King MA; Mareci TH; Sarntinoranont M; Carney PR
PLoS One; 2013; 8(11):e80606. PubMed ID: 24260433
[TBL] [Abstract][Full Text] [Related]
5. Convection-Enhanced Drug Delivery: Experimental and Analytical Studies of Infusion Behavior in an In Vitro Brain Surrogate.
Noh DH; Zadeh AH; Zhang H; Wang F; Ryu S; Zhang C; Kim S
Ann Biomed Eng; 2024 Jun; 52(6):1693-1705. PubMed ID: 38502430
[TBL] [Abstract][Full Text] [Related]
6. MRI-based computational model of heterogeneous tracer transport following local infusion into a mouse hind limb tumor.
Magdoom KN; Pishko GL; Rice L; Pampo C; Siemann DW; Sarntinoranont M
PLoS One; 2014; 9(3):e89594. PubMed ID: 24619021
[TBL] [Abstract][Full Text] [Related]
7. Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma.
Butowski NA; Bringas JR; Bankiewicz KS; Aghi MK
J Neurosurg; 2019 Aug; 133(3):611-613. PubMed ID: 31374552
[No Abstract] [Full Text] [Related]
8. An atypical adverse reaction to iron infusion: a case report.
Belviso F; Marcianò T; Silva M
Intern Emerg Med; 2024 May; ():. PubMed ID: 38696075
[No Abstract] [Full Text] [Related]
9. Strategies to enhance the distribution of nanotherapeutics in the brain.
Zhang C; Mastorakos P; Sobral M; Berry S; Song E; Nance E; Eberhart CG; Hanes J; Suk JS
J Control Release; 2017 Dec; 267():232-239. PubMed ID: 28739449
[TBL] [Abstract][Full Text] [Related]
10. Novel contrast mixture improves bladder wall contrast for visualizing bladder injury.
Tyagi P; Janicki JJ; Hitchens TK; Foley LM; Kashyap M; Yoshimura N; Kaufman J
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F155-F162. PubMed ID: 28356290
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting.
Marianecci C; Rinaldi F; Hanieh PN; Di Marzio L; Paolino D; Carafa M
Drug Des Devel Ther; 2017; 11():325-335. PubMed ID: 28184152
[TBL] [Abstract][Full Text] [Related]
12. Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.
Salvalaio M; Rigon L; Belletti D; D'Avanzo F; Pederzoli F; Ruozi B; Marin O; Vandelli MA; Forni F; Scarpa M; Tomanin R; Tosi G
PLoS One; 2016; 11(5):e0156452. PubMed ID: 27228099
[TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.
Jahangiri A; Chin AT; Flanigan PM; Chen R; Bankiewicz K; Aghi MK
J Neurosurg; 2017 Jan; 126(1):191-200. PubMed ID: 27035164
[TBL] [Abstract][Full Text] [Related]
14. Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.
Malhotra M; Tomaro-Duchesneau C; Saha S; Prakash S
J Pharm (Cairo); 2013; 2013():812387. PubMed ID: 26555995
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced drug delivery for gliomas.
Healy AT; Vogelbaum MA
Surg Neurol Int; 2015; 6(Suppl 1):S59-67. PubMed ID: 25722934
[TBL] [Abstract][Full Text] [Related]
16. The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.
Luther N; Zhou Z; Zanzonico P; Cheung NK; Humm J; Edgar MA; Souweidane MM
Neuro Oncol; 2014 Jun; 16(6):800-6. PubMed ID: 24526309
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a chronic unilateral intraparenchymal drug delivery system in a swine model.
Kim I; Paek S; Nelson BD; Knight EJ; Marsh MP; Bieber AJ; Bennet KE; Lee KH
J Neurosci Methods; 2014 Apr; 227():29-34. PubMed ID: 24486877
[TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations.
Barua NU; Gill SS; Love S
Brain Pathol; 2014 Mar; 24(2):117-27. PubMed ID: 23944716
[TBL] [Abstract][Full Text] [Related]
19. Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.
Martin JA; Maris AS; Ehtesham M; Singer RJ
J Vis Exp; 2012 Nov; (69):e50019. PubMed ID: 23222697
[TBL] [Abstract][Full Text] [Related]
20. A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery.
Yun J; Sonabend AM; Ulasov IV; Kim DH; Rozhkova EA; Novosad V; Dashnaw S; Brown T; Canoll P; Bruce JN; Lesniak MS
J Clin Neurosci; 2012 Jun; 19(6):875-80. PubMed ID: 22516547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
